1. Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Issue 1 (December 2015) Authors: Zhao, Helong; Wilkie, Tasha; Deol, Yadwinder; Sneh, Amita; Ganju, Akaansha; Basree, Mustafa; Nasser, Mohd; Ganju, Ramesh Journal: Molecular cancer Issue: Volume 14:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MiR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Issue 1 (December 2015) Authors: Zhao, Helong; Wilkie, Tasha; Deol, Yadwinder; Sneh, Amita; Ganju, Akaansha; Basree, Mustafa; Nasser, Mohd; Ganju, Ramesh Journal: Molecular cancer Issue: Volume 14:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MiR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Issue 1 (December 2015) Authors: Zhao, Helong; Wilkie, Tasha; Deol, Yadwinder; Sneh, Amita; Ganju, Akaansha; Basree, Mustafa; Nasser, Mohd; Ganju, Ramesh Journal: Molecular cancer Issue: Volume 14:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MiR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Issue 1 (December 2015) Authors: Zhao, Helong; Wilkie, Tasha; Deol, Yadwinder; Sneh, Amita; Ganju, Akaansha; Basree, Mustafa; Nasser, Mohd; Ganju, Ramesh Journal: Molecular cancer Issue: Volume 14:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗